Fentanyl Transdermal Matrix Patch ZR-02-01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Fentanyl Transdermal Matrix Patch ZR-02-01, covering 2012-06-05 to 2012-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain [Phase 2]